ARTL (Artelo Biosciences, Inc. Common Stock) Stock Analysis - Insider Trades
Artelo Biosciences, Inc. Common Stock (ARTL) is a publicly traded Healthcare sector company. As of May 21, 2026, ARTL trades at $1.43 with a market cap of $3.19M and a P/E ratio of 0.00. ARTL moved +3.68% today. Year to date, ARTL is -63.59%; over the trailing twelve months it is -91.84%. Its 52-week range spans $1.25 to $85.80. Rallies surfaces ARTL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who is trading ARTL stock inside the company?
Recent ARTL insider activity includes Gorgas Gregory D. bought 1.20K and Gorgas Gregory D. bought 1.20K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
ARTL Key Metrics
Key financial metrics for ARTL
Metric
Value
Price
$1.43
Market Cap
$3.19M
P/E Ratio
0.00
EPS
$0.00
Dividend Yield
0.00%
52-Week High
$85.80
52-Week Low
$1.25
Volume
9.98K
Avg Volume
0
Revenue (TTM)
$0
Net Income
$-9.83M
Gross Margin
0.00%
Recent ARTL Insider Trades
Gorgas Gregory D. bought 1.20K (~$4.80K) on Aug 12, 2022.
Gorgas Gregory D. bought 1.20K (~$4.84K) on Aug 11, 2022.
ARTL analyst coverage data. Average price target: $0.00.
Common questions about ARTL
Who is trading ARTL stock inside the company?
Recent ARTL insider activity includes Gorgas Gregory D. bought 1.20K and Gorgas Gregory D. bought 1.20K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for ARTL?
Yes. Rallies tracks ARTL insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is ARTL research on Rallies investment advice?
No. Rallies provides research, data, and educational context for ARTL. It does not provide personalized investment advice.